- Concept UI
- M0028268
- Scope Note
- A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)
- Terms
-
Antineoplastic Agents, Alkylating
Preferred Term
Term UI
T056347
Date01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Alkylating Antineoplastic Agents
Term UI
T056344
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Alkylating Antineoplastic Drugs
Term UI
T056350
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Alkylating Antineoplastics
Term UI
T056348
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Alkylating Agents, Antineoplastic
Term UI
T056346
Date08/26/1994
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antineoplastic Alkylating Agents
Term UI
T056345
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antineoplastic Drugs, Alkylating
Term UI
T056352
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antineoplastics, Alkylating
Term UI
T056349
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Alkylating Drugs, Antineoplastic
Term UI
T056351
Date03/21/1995
LexicalTag
NON
ThesaurusID
NLM (1996)